Heintz Jay, Kahn Barbara, Kramer Andrew
Department of Urology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Can J Urol. 2011 Apr;18(2):5660-2.
To report an unusual presentation of metastatic prostate cancer to the orbit in an immunosuppressed patient, who received a novel palliative treatment regimen.
A 56 year old HIV+ man presented with proptosis and unilateral blindness. The diagnosis, work up, and treatment are outlined.
Metastatic prostate cancer to the orbit is diagnosed, and the treatment with IMRT and hormone ablation is explored.
We outline the literature and current thinking surrounding prostate cancer metastases to the orbit. HIV+ patients currently enjoy longer life expectancies, with the caveat that their immunosuppressed status may lead to more unusual metastatic presentations. Treatments and palliation will continue to evolve as these new cases emerge.
报告一例免疫抑制患者发生转移性前列腺癌累及眼眶的罕见病例，该患者接受了一种新的姑息治疗方案。
一名56岁的HIV阳性男性出现眼球突出和单眼失明。概述了诊断、检查及治疗过程。
诊断为转移性前列腺癌累及眼眶，并探讨了调强放射治疗（IMRT）和激素消融治疗。
我们概述了关于前列腺癌转移至眼眶的文献及当前的观点。HIV阳性患者目前预期寿命更长，但需注意其免疫抑制状态可能导致更罕见的转移表现。随着这些新病例的出现，治疗和姑息治疗将不断发展。
